Incorporating patient centric sampling into multi-center clinical trials: Summary of a PCSIG workshop

Challenges and proposed solutions to incorporating patient centric sampling into clinical trials.
The PCSIG convened a two-day workshop on ‘Incorporating Patient Centric Sampling into Multi-center Clinical Trials’ at Roche’s facilities in Welwyn Garden City, UK on 11 and 12 June 2024. The event was hosted by Neil Spooner (Chair, PCSIG) and attended by 48 individuals from organizations representing patient engagement, pharmaceutical and biotech companies, contract research organizations, technology and solutions vendors, publishing and consulting sectors.
The purpose of the workshop was to:

Outline the key stages associated with the implementation of PCS for multi-center clinical trials
Define the challenges to implementation of PCS for multi-center clinical trials
Identify how we can overcome these challenges

In this webinar, we will outline the key outcomes from the workshop and discuss next steps on the roadmap to the use of PCS in clinical trials.
Of interest to any stakeholders involved with, or interested in, patient centric sampling, including: patients, healthcare providers, regulators, scientific experts, technology providers and policy makers.
Moderator Neil Spooner (Founder, PCSIG) is joined by the workshop facilitators to discuss challenges, solutions and resulting actions.

Your details

By submitting this form you are agreeing to our Terms & Conditions and Privacy Policy, and agree to receiving relevant emails from The Evidence Base about the latest news and editorial features.

Terms & Conditions

I agree to receive third party emails to keep me informed of relevant products and services relevant to my industry.

I agree for my registration data to be transferred to the lead partner organization (PCSIG).

Date and time

Wednesday

October

16:00 BST

What you will learn:

Challenges of implementing PCS in multi-center clinical trials and potential solutions, focusing on the following key stages along the clinical trial pathway:

Requirements and concerns of patients
Study planning
Logistics
Study conduct
Regulatory interactions

Moderated by:

Neil Spooner
Founder, Patient Centric Sampling Interest Group

Neil Spooner (PhD, CChem, FRSC) is the Co-founder, Chair and director of the Patient Centric Sampling Interest Group, CIC, a not-for-profit organisation that brings together a variety of interested parties who wish to develop and promote the use of patient centric sampling technologies for blood, plasma and other human matrices to better facilitate the advancement of human healthcare and well-being. Neil is also the founder and Director of Spooner Bioanalytical Solutions, a consultancy based in Hertford, UK. In addition, Neil is a Senior Visiting Research Fellow at the School of Life and Medical Sciences, University of Hertfordshire (Hertfordshire, UK), the Editor in Chief of Bioanalysis Journal and the Chair of the Reid Bioanalytical Forum. He has published extensively, with over 70 peer reviewed manuscripts and more than 50 podium presentations at international Conferences and Symposia.

Joined by:

Alex Georgiou (Roche)
Brenda Yanak (CT Partners)
Chi Pakarinen (MediPace)
Daniel Baker (AstraZeneca)
Graeme Clark (Parexel)
Jasbinder Bajwa (Roche)
Jennifer Russell (Roche)
Jenny Royle (MediPace)
Navdeep Kalia (Roche)

Share this webinar